Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos
The role of local radiation in the treatment of non-hodgkin lymphoma in children
β Scribed by Jereb, Berta ;Wollner, Norma ;Kosloff, Cynthia ;Exelby, Philip
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 496 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Eightyβone patients between 1 and 15 years of age with nonβHodgkin lymphoma were seen at Memorial SloanβKettering Cancer Center (MSKCC) in an 8βyear period ending December 1973. There was no statistically significant difference among the survival distributions for site or histologic type. The patients also were divided into three groups according to the chemotherapeutic regimen employed in their care, and further subdivided as to whether they received βcurativeβ radiotherapeutic attempts. Children treated with multiple agent chemotherapeutic regimen (LSAβ2) did significantly better than children of the LSAβ1 or nonprotocol (NP) group. Children with Stage I and Stage II disease did significantly better than children with Stage III and Stage IV disease. Radiation therapy as employed in this study prevented recurrence of local disease. All patients in whom the disease recurred died within a year from the appearance of recurrence. However, no statistically significant association between radiation and survival could be shown in this series.
π SIMILAR VOLUMES
## Abstract Our objective was to investigate if there was __(i)__ an excess risk of leukaemia/nonβHodgkin's lymphoma among children of male radiation workers at the Sellafield nuclear installation in Cumbria, northwest England; __(ii)__ a doseβresponse relationship between fathers' preconceptional
Recent studies specifically directed toward assessing the outcome of older patients with non-Hodgkin's lymphoma (NHL) indicate that age per se is an important and independent prognostic factor for response and survival. We report a review of the clinical trials of the literature and the Aviano Group